Lv112
68 积分 2025-02-23 加入
Breakthrough therapy designations in China and the United States
1小时前
已完结
The Impact of Cytoreduction on Blinatumomab Outcomes for Relapsed or Refractory B‐ALL With High Disease Burden
3天前
已完结
The discussion on the differences in immune microenvironment between low-risk and high-risk myelodysplastic syndromes and acute myeloid leukemia
3天前
已完结
The Impact of Cytoreduction on Blinatumomab Outcomes for Relapsed or Refractory B‐ALL With High Disease Burden
3天前
已完结
Significance of Pre‐ and Posttransplant Minimal Residual Disease on Transplant Outcomes in Core‐Binding Factor Acute Myeloid Leukemia
4天前
已完结
Leveraging Machine Learning for Rapid and Accurate Diagnosis of Acute Leukemia
4天前
已完结
The role of stem cell transplantation in the modern management of multiple myeloma
5天前
已关闭
How I treat Ph+ acute lymphoblastic leukemia
5天前
已完结
Application of Targeted RNA‐Sequencing in High‐Risk B‐Cell Acute Lymphoblastic Leukemia (B‐ALL): Identifying Fusions, IKZF1 Deletions, and CRLF2 Expression in an Indian Cohort
6天前
已完结
Can Flow Cytometry Immunophenotyping Predict Cytogenetic Abnormalities in Acute Myeloid Leukemia? A Focus on Myelodysplasia‐Related Cytogenetic Abnormalities
6天前
已完结
皖公网安备34019202002308
